CI
AMGN icon

Corient IA’s Amgen AMGN Stock Holding History

Corient IA’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
890
– – 0.3% 106
2026
Q1 		$313K Sell
890
-110
-11% -$39.2K 0.29% 132
2025
Q4 		$327K Hold
1,000
– – 0.31% 136
2025
Q3 		$282K Hold
1,000
– – 0.21% 189
2025
Q2 		$279K Hold
1,000
– – 0.16% 233
2025
Q1 		$312K Buy
+1,000
New +$295K 0.22% 196

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Corient IA's AMGN Position: Q2 2026 in Review

Corient IA held its Amgen (AMGN) position steady in Q2 2026 at 890 shares worth $322K. The position accounts for 0.3% of the portfolio, ranked #106.

Corient IA first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $327K in Q4 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Corient IA held 890 shares of Amgen worth $322K as of Q2 2026.
  • Corient IA left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.3% of Corient IA's portfolio in Q2 2026, its #106 holding.
  • Corient IA first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's Amgen position peaked at $327K in Q4 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.